Back to search
FDAFDA · Food and drugs·Recall number D-0148-2018

All Sterile Products within expiry

Published December 27, 2017 · Recall initiated: August 17, 2017

Summary

FDA records drug Class II recall D-0148-2018, published December 27, 2017 and initiated August 17, 2017. Recalling firm: Vital Rx, Inc. dba Atlantic Pharmacy and Compounding; Status: Terminated; Reported quantity: 61 Products; Lot: Lack of Sterility Assurance: A recent FDA inspection revealed poor aseptic production practices that result in lack of sterility assurance of products. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility .

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Vital Rx, Inc. dba Atlantic Pharmacy and Compounding
Distributor
Nationwide.
Lot
Lack of Sterility Assurance: A recent FDA inspection revealed poor aseptic production practices that result in lack of sterility assurance of products
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was All Sterile Products within expiry recalled?

Yes. FDA published recall D-0148-2018 on December 27, 2017. Reported hazard: Lack of Assurance of Sterility .

What should I do if I have this product?

Voluntary: Firm initiated · Press Release